Discover Southside Bancshares' Q1 2025 insights: robust $1.9B loan pipeline, strategic C&I growth, and focused margin improvements.

Discover Verona Pharma's Q1 2025 earnings report, featuring Ohtuvayre's rapid adoption, sales milestones, and global expansion.

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

Q1 2025 Management View Christophe Beck, Chairman & CEO, highlighted strong Q1 2025 results with organic sales growth of 3% and a 12% increase in EPS. He attributed this success to market share gains, ...

Q1 2025 Management View CEO Marty Birmingham highlighted the transformative impact of the late 2024 investment securities ...